Truist Financial Forecasts Strong Price Appreciation for Integer (NYSE:ITGR) Stock

Integer (NYSE:ITGR) had its price target lifted by stock analysts at Truist Financial from $97.00 to $110.00 in a research report issued to clients and investors on Thursday, Marketbeat.com reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price objective would indicate a potential upside of 15.11% from the company’s current price.

Other equities research analysts also recently issued research reports about the company. Piper Sandler reaffirmed an “overweight” rating and set a $97.00 price target (up from $87.00) on shares of Integer in a report on Friday, May 1st. Zacks Research downgraded shares of Integer from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. Finally, Citigroup raised their target price on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $101.14.

Integer Price Performance

Shares of NYSE ITGR opened at $95.56 on Thursday. The business’s 50 day moving average price is $91.53 and its two-hundred day moving average price is $87.50. The company has a market cap of $3.25 billion, a PE ratio of 23.83, a price-to-earnings-growth ratio of 2.37 and a beta of 0.64. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. Integer has a twelve month low of $62.00 and a twelve month high of $116.31.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The business had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. During the same quarter in the prior year, the company earned $1.31 EPS. Integer’s quarterly revenue was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, analysts predict that Integer will post 6.04 EPS for the current year.

Institutional Trading of Integer

Several institutional investors have recently added to or reduced their stakes in the company. Tudor Investment Corp ET AL increased its position in Integer by 50,787.5% during the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after buying an additional 29,442,029 shares during the period. Vanguard Group Inc. boosted its position in shares of Integer by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider’s stock valued at $304,791,000 after acquiring an additional 14,465 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Integer by 6.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,484,396 shares of the medical equipment provider’s stock valued at $130,620,000 after acquiring an additional 90,277 shares during the period. State Street Corp grew its stake in shares of Integer by 3.7% in the fourth quarter. State Street Corp now owns 1,371,767 shares of the medical equipment provider’s stock valued at $107,588,000 after acquiring an additional 48,463 shares in the last quarter. Finally, Viking Global Investors LP grew its stake in shares of Integer by 9.1% in the second quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock valued at $157,889,000 after acquiring an additional 106,692 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.